Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Myeloma Survival Benefit May Help Amgen's Kyprolis Stave Off Competition

Mar 01 2017

• By Emily Hayes

White blood cells in peripheral blood smear, Wright stain

Related Content

Amgen’s Biggest Seller Enbrel Hit By Pricing Pressures, Competition

Oct 28 2016

Another Sea Change In Myeloma Promised By New Therapies, Combos

Jun 15 2016

Kyprolis Wins Full Monotherapy OK, Broader Combo Use

Jan 22 2016

Amgen's Kyprolis Miss In First-Line Myeloma Surprising, But Clinically Irrelevant

Sep 27 2016

Related Companies

Amgen, Inc.

Takeda Pharmaceutical Co. Ltd.

Bristol Myers Squibb Company

Johnson & Johnson

Bristol Myers Squibb Company

Additional Topics

Clinical Trials Research & Development Cancer BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.